Relaxing vacations have been touted as a way to improve Ireland’s economy, and the Government hopes that sales of the drug will drive more people to work and stay home.
A report released on Monday by the OECD said relaxation sales have grown at an annual rate of about 8% since 2011.
The report said the growth in relaxation sales had been driven by sales of muscle relaxants, which are used to relax muscles.
“The relaxation sector has a particularly strong future potential,” the OECD report said.
Although relaxation sales are growing, they are still lower than those enjoyed by the Irish economy as a whole.
It said relaxation revenues have fallen by about €500m since 2011, while revenue from sales of non-prescription medicines has grown by around €5bn since 2007.
This has led to a deficit of around €4.7bn for the Irish budget.
Revenues from sales, which cover healthcare and other public services, are also falling.
According to the report, relaxation sales rose by 8.5% from €1.9bn in 2011 to €2.6bn in 2014, and a further 6.5%, from €2bn in 2015 to €3.2bn last year.
The report says that sales in 2014-15 were up 7.3%, from around 1.9m people to 1.6m.
It also said relaxation revenue grew by 10.4% from 2014-16 to 2015-16.